Carolina Yazmin Dominguez Maldonado

Ms. Carolina Yazmin Dominguez Maldonado

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GTGerman Matias Traglia
German Matias Traglia
FPFernando pasteran
Fernando pasteran
SMSamyar Moheb
Samyar Moheb
UAUsman Akhtar
Usman Akhtar
SGSebastian Gonzalez
Sebastian Gonzalez
María Soledad RamírezMaría Soledad Ramírez
María Soledad Ramírez
The rise of antibiotic-resistant bacteria in clinical settings has become a significant global concern. Among these bacteria, Acinetobacter baumannii stands out due to its remarkable ability to acquire resistance genes and persist in hospital environments, leading to some of the most challenging infections. Horizontal gene transfer (HGT) plays a crucial role in the evolution of this pathogen. The A. baumannii AMA205 strain, belonging to sequence type ST79, was isolated from a COVID-19 patient in Argentina in 2021. This strain’s antimicrobial resistance profile is notable as it harbors multiple resistance genes, some of which had not been previously described in this species. The AmpC family β-lactamase blaCMY-6, commonly found in Enterobacterales, had never been detected in A. baumannii before. Furthermore, this is the first ST79 strain known to carry the carbapenemase blaNDM-1 gene. Other acquired resistance genes include the carbapenemase blaOXA-23, further complicating treatment. Susceptibility testing revealed high resistance to most antibiotic families, including cefiderocol, with significant contributions from blaCMY-6 and blaNDM-1 genes to the cephalosporin and carbapenem resistance profiles. The A. baumannii AMA205 genome also contains genetic traits coding for 111 potential virulence factors, such as the iron-uptake system and biofilm-associated proteins. This study underscores A. baumannii’s ability to acquire multiple resistance genes and highlights the need for alternative therapies and effective antimicrobial stewardship to control the spread of these highly resistant strains.

28 May 2024 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
GTGerman Matias Traglia
German Matias Traglia
NFNicholas Furtado
Nicholas Furtado
JEJenny Escalante
Jenny Escalante
MAMarisa Almuzara
Marisa Almuzara
RCRoxana Marisa Cittadini
Roxana Marisa Cittadini
María Soledad RamírezMaría Soledad Ramírez
María Soledad Ramírez

25 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GTGerman Matias Traglia
German Matias Traglia
FPFernando pasteran
Fernando pasteran
SMSamyar Moheb
Samyar Moheb
UAUsman Akhtar
Usman Akhtar
SGSebastian Gonzalez
Sebastian Gonzalez
María Soledad RamírezMaría Soledad Ramírez
María Soledad Ramírez
The rise of antibiotic-resistant bacteria in clinical settings has become a significant global concern. Among these bacteria, Acinetobacter baumannii stands out due to its remarkable ability to acquire resistance genes and persist in hospital environments, leading to some of the most challenging infections. Horizontal gene transfer (HGT) plays a crucial role in the evolution of this pathogen. The A. baumannii AMA205 strain, belonging to sequence type ST79, was isolated from a COVID-19 patient in Argentina in 2021. This strain’s antimicrobial resistance profile is notable as it harbors multiple resistance genes, some of which had not been previously described in this species. The AmpC family β-lactamase blaCMY-6, commonly found in Enterobacterales, had never been detected in A. baumannii before. Furthermore, this is the first ST79 strain known to carry the carbapenemase blaNDM-1 gene. Other acquired resistance genes include the carbapenemase blaOXA-23, further complicating treatment. Susceptibility testing revealed high resistance to most antibiotic families, including cefiderocol, with significant contributions from blaCMY-6 and blaNDM-1 genes to the cephalosporin and carbapenem resistance profiles. The A. baumannii AMA205 genome also contains genetic traits coding for 111 potential virulence factors, such as the iron-uptake system and biofilm-associated proteins. This study underscores A. baumannii's ability to acquire multiple resistance genes and highlights the need for alternative therapies and effective antimicrobial stewardship to control the spread of these highly resistant strains.

27 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAngel J. Magana
Angel J. Magana
DNDavid Ngo
David Ngo
KBKenneth Burgos
Kenneth Burgos
CMCarolina Yazmin Dominguez Maldonado
Carolina Yazmin Dominguez Maldonado
OAOmniya Abdelmaksoud
Omniya Abdelmaksoud
Marcelo TolmaskyMarcelo Tolmasky
Marcelo Tolmasky
The ongoing antibiotic resistance crisis is among the most pressing public health chal-lenges. The rise and dissemination of multidrug-resistant bacterial pathogens is reaching the point when some become untreatable. Consequently, besides discovering novel antibiotics, alternative strategies must be explored to manage the problem. One of them is the development of inhibitors that can overcome resistance to antibiotics currently in use. Resistance to aminoglycosides such as amikacin is mainly due to the action of aminoglycoside modifying enzymes. Despite being refractory to most resistance en-zymes, the semisynthetic amikacin is inactivated by the action of aminoglycoside 6’-N-acetyltransferases type I [AAC(6')-I], of which AAC(6')-Ib is the most common in Gram-negative pathogens. The recent discovery that certain divalent and monovalent cations can interfere with enzymatic acetylation catalyzed by AAC(6')-Ib has opened up new possibilities for developing formulations that combine antibiotics with these cations to enhance their efficacy. Addition of CdCl2 to in vitro enzymatic assays inhibited the transfer of an acetyl group to the 6'-N position of amikacin, kanamycin, and tobramycin. This result demonstrated the potential of Cd2+ as an adjuvant to aminoglycosides that can become effective for treating infections resistant due to AAC(6')-Ib. It was initially dis-appointing that, as with other divalent cations, addition of CdCl2 to cultures of bacteria harboring AAC(6')-Ib did not reverse resistance. However, the inhibitory action of Cd2+ became evident when it was added to cultures in complex with the ionophore pyrithione. The complex efficiently inhibited resistance in Acinetobacter baumannii and Klebsiella pneumoniae harboring AAC(6')-Ib. Furthermore, the combination efficiently inhibited amikacin resistance in carbapenem-resistant K. pneumoniae clinical isolates. These results add another cation to the arsenal of potential adjuvants for aminoglycosides, which could be developed either alone or in coordination complexes with ionophores to treat multi-drug-resistant infections.